Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1

Interventions

Carboplatin 17Filgrastim 16Ifosfamide 13Etoposide 13Paclitaxel 11Peripheral Blood Stem Cell Transplantation 10Cisplatin 6Thiotepa 5Therapeutics 5Cyclophosphamide 5Temozolomide 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Granulocyte Colony-Stimulating Factor 4Flow Cytometry 4Bleomycin 4Taxes 3Radiotherapy 3Methylprednisolone 3Magnetic Resonance Spectroscopy 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3sargramostim 2pegfilgrastim 2liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2aldesleukin 2aflibercept 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Vinblastine × Gynecologic × Clear all
NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
105 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡